Stay updated on IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Sign up to get notified when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.

Latest updates to the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page
- Check7 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check36 days agoChange DetectedA new site revision (v3.4.2) was added; previous notices about funding/operating status and v3.4.1 were removed.SummaryDifference0.9%

- Check43 days agoChange DetectedAdded a time-sensitive government funding notice about the NIH Clinical Center's status and updated the history to revision v3.4.1, with v3.4.0 removed.SummaryDifference0.9%

- Check50 days agoChange DetectedUI updates include showing the glossary, color-coded highlights for additions (green) and deletions (red), and a new revision stamp (v3.4.0) replacing the previous version. These changes are formatting and tagging improvements rather than substantive content updates; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference1%

- Check64 days agoChange DetectedRecord History was updated with a new revision entry v3.3.4. The previous revision v3.3.3 was removed from the history.SummaryDifference0.1%

- Check85 days agoChange DetectedRevision: v3.3.3 was added to the page, signaling a minor update to the record history. The HHS Vulnerability Disclosure link and the previous Revision: v3.3.2 entry were removed from the footer; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and IBI308 vs High-Dose Interferon in Acral Melanoma Clinical Trial page.